Advertisement
APYX vs STRR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Buy and STRR is a Buy.
APYX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for APYX turned positive on October 12, 2026. Looking at past instances where APYX's MACD turned positive, the stock continued to rise in 41 of 47 cases over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where APYX's RSI Indicator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on APYX as a result. In 83 of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
Following a +7.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where APYX advanced for three days, in 196 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
APYX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where APYX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for APYX entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.627) is normal, around the industry mean (3.870). P/E Ratio (-13.450) is within average values for comparable stocks, (1.382). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (2.196) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. APYX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
STRR sees its Stochastic Oscillator recovers from oversold territory
On October 27, 2026, the Stochastic Oscillator for STRR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In 52 of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for STRR just turned positive on October 27, 2026. Looking at past instances where STRR's MACD turned positive, the stock continued to rise in 30 of 46 cases over the following month. The odds of a continued upward trend are 65%.
Following a +2.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where STRR advanced for three days, in 172 of 236 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
STRR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 43 of 79 cases where STRR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STRR as a result. In 96 of 119 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
STRR moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for STRR moved below the 200-day moving average on October 01, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.605) is normal, around the industry mean (4.965). P/E Ratio (-3.542) is within average values for comparable stocks, (1.058). Projected Growth (PEG Ratio) (0.194) is also within normal values, averaging (1.448). Dividend Yield (0.000) settles around the average of (1.355) among similar stocks. P/S Ratio (0.171) is also within normal values, averaging (0.884).
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. STRR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
APYX | STRR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 69 | 34 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 22 Undervalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 96 | |
PRICE GROWTH RATING 1..100 | 63 | 56 | |
P/E GROWTH RATING 1..100 | 14 | 28 | |
SEASONALITY SCORE 1..100 | 50 | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STRR's Valuation (20) in the Medical Specialties industry is in the same range as APYX (22). This means that STRR’s stock grew similarly to APYX’s over the last 12 months.
STRR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as APYX (100). This means that STRR’s stock grew similarly to APYX’s over the last 12 months.
STRR's SMR Rating (96) in the Medical Specialties industry is in the same range as APYX (99). This means that STRR’s stock grew similarly to APYX’s over the last 12 months.
STRR's Price Growth Rating (56) in the Medical Specialties industry is in the same range as APYX (63). This means that STRR’s stock grew similarly to APYX’s over the last 12 months.
APYX's P/E Growth Rating (14) in the Medical Specialties industry is in the same range as STRR (28). This means that APYX’s stock grew similarly to STRR’s over the last 12 months.
| APYX | STRR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | N/A |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 87% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 65% |
| Advances ODDS (%) | 2 days ago 84% | 3 days ago 73% |
| Declines ODDS (%) | 8 days ago 89% | 9 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 72% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APYX’s FA Score shows that 2 FA rating(s) are green while STRR’s FA Score has 2 green FA rating(s).
- APYX’s FA Score: 2 green, 3 red.
- STRR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APYX’s TA Score shows that 5 TA indicator(s) are bullish while STRR’s TA Score has 5 bullish TA indicator(s).
- APYX’s TA Score: 5 bullish, 3 bearish.
- STRR’s TA Score: 5 bullish, 4 bearish.
Price Growth
APYX (@Medical/Nursing Services) experienced а +11.62% price change this week, while STRR (@Other Consumer Services) price change was +1.13% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.24%. For the same industry, the average monthly price growth was -6.31%, and the average quarterly price growth was -7.56%.
The average weekly price growth across all stocks in the @Other Consumer Services industry was -3.41%. For the same industry, the average monthly price growth was -4.26%, and the average quarterly price growth was +20.95%.
Reported Earning Dates
APYX is expected to report earnings on Nov 05, 2026.
STRR is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Medical/Nursing Services (+3.24% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Other Consumer Services (-3.41% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
Advertisement
APYX and
Correlation & Price change
A.I.dvisor tells us that APYX and SGHT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APYX and SGHT's prices will move in lockstep.
| Ticker / NAME | Correlation To APYX | 1D Price Change % | ||
|---|---|---|---|---|
| APYX | 100% | +3.07% | ||
| SGHT - APYX | 28% Poorly correlated | +3.57% | ||
| ITOC - APYX | 26% Poorly correlated | -1.69% | ||
| CLPT - APYX | 25% Poorly correlated | +1.23% | ||
| EMBC - APYX | 25% Poorly correlated | +1.55% | ||
| A - APYX | 25% Poorly correlated | -0.18% | ||
More | ||||
STRR and
Correlation & Price change
A.I.dvisor indicates that over the last year, STRR has been closely correlated with CATX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRR jumps, then CATX could also see price increases.
| Ticker / NAME | Correlation To STRR | 1D Price Change % | ||
|---|---|---|---|---|
| STRR | 100% | -3.06% | ||
| CATX - STRR | 88% Closely correlated | -6.40% | ||
| NSYS - STRR | 29% Poorly correlated | -6.31% | ||
| CERS - STRR | 23% Poorly correlated | +0.83% | ||
| LUNG - STRR | 23% Poorly correlated | +25.60% | ||
| MODD - STRR | 22% Poorly correlated | -10.42% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PHO | 73.93 | 1.49 | +2.06% |
| Invesco Water Resources ETF (PHO) | |||
| TXNU | 53.72 | 1.02 | +1.94% |
| Direxion Daily TXN Bull 2X ETF (TXNU) | |||
| XLVI | 27.48 | 0.24 | +0.88% |
| State Street Health Care Select Sector SPDR Premium Income ETF (XLVI) | |||
| PBP | 23.35 | N/A | N/A |
| Invesco S&P 500 BuyWrite ETF (PBP) | |||
| PSMO | 33.82 | N/A | N/A |
| Pacer Swan SOS Moderate (October) ETF | |||